FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shlomo Dagan

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Bracha Naim; David Zbaida; Shlomo Dagan; Ruti Kapon; Ziv Reich
Cargo surface hydrophobicity is sufficient to overcome the nuclear pore complex selectivity barrier.
Yoav Barnea; Yehuda Carmeli; Lewis F Neville; Hamutal Kahel-Reifer; Rachel Eren; Shlomo Dagan; Shiri Navon-Venezia
Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model.
Eithan Galun; Norah A Terrault; Rachel Eren; Arie Zauberman; Ofer Nussbaum; Dov Terkieltaub; Meirav Zohar; Rachel Buchnik; Zvi Ackerman; Rifaat Safadi; Yaffa Ashur; Sara Misrachi; Yael Liberman; Ludmila Rivkin; Shlomo Dagan
Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: safety and antiviral activity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shlomo Dagan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Bracha Naim; David Zbaida; Shlomo Dagan; Ruti Kapon; Ziv Reich
Cargo surface hydrophobicity is sufficient to overcome the nuclear pore complex selectivity barrier.
The EMBO journal 2009;28(18):2697-705.
2009: Yoav Barnea; Yehuda Carmeli; Lewis F Neville; Hamutal Kahel-Reifer; Rachel Eren; Shlomo Dagan; Shiri Navon-Venezia
Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model.
Burns : journal of the International Society for Burn Injuries 2009;35(3):390-6.
2007: Eithan Galun; Norah A Terrault; Rachel Eren; Arie Zauberman; Ofer Nussbaum; Dov Terkieltaub; Meirav Zohar; Rachel Buchnik; Zvi Ackerman; Rifaat Safadi; Yaffa Ashur; Sara Misrachi; Yael Liberman; Ludmila Rivkin; Shlomo Dagan
Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: safety and antiviral activity.
Journal of hepatology 2007;46(1):37-44.
2006: Thomas D Schiano; Michael Charlton; Zobair M Younossi; Eithan Galun; Timothy Pruett; Ran Tur-Kaspa; Rachel Eren; Shlomo Dagan; Neil Graham; Paulette V Williams; John Andrews
Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized study.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006;12(9):1381-9.
2006: Yoav Barnea; Yehuda Carmeli; Eyal Gur; Boris Kuzmenko; Andrea Gat; Lewis F Neville; Rachel Eren; Shlomo Dagan; Shiri Navon-Venezia
Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
Plastic and reconstructive surgery 2006;117(7):2284-91.
2006: M Luisa Gil; Shlomo Dagan; Rachel Eren; Daniel Gozalbo
Evaluation of the usefulness of anti-glyceraldehyde-3-phosphate dehydrogenase antibodies as a treatment for invasive candidiasis in a murine model.
Antonie van Leeuwenhoek 2006;89(3-4):345-50.
2006: Mali Ketzinel-Gilad; Arie Zauberman; Ofer Nussbaum; Yariv Shoshany; Ofer Ben-Moshe; Orit Pappo; Yaakov Felig; Ehud Ilan; Hanna Wald; Shlomo Dagan; Eithan Galun
The use of the hydrodynamic HBV animal model to study HBV biology and anti-viral therapy.
Hepatology research : the official journal of the Japan Society of Hepatology 2006;34(4):228-37.
2006: Rachel Eren; Dorit Landstein; Dov Terkieltaub; Ofer Nussbaum; Arie Zauberman; Judith Ben-Porath; Judith Gopher; Rachel Buchnick; Riva Kovjazin; Ziva Rosenthal-Galili; Sigal Aviel; Ehud Ilan; Yariv Shoshany; Lewis F Neville; Tal Waisman; Ofer Ben-Moshe; Alberto Kischitsky; Steven K H Foung; Zhen-Yong Keck; Orit Pappo; Ahmed Eid; Oded Jurim; Gideon Zamir; Eithan Galun; Shlomo Dagan
Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients.
Journal of virology 2006;80(6):2654-64.
2005: Lewis F Neville; Yoav Barnea; Orly Hammer-Munz; Eyal Gur; Boris Kuzmenko; Hamutal Kahel-Raifer; Rachel Eren; Adi Elkeles; Kanneganti G K Murthy; Csaba Szabó; Andrew L Salzman; Shlomo Dagan; Yehuda Carmeli; Shiri Navon-Venezia
Antibodies raised against N'-terminal Pseudomonas aeruginosa flagellin prevent mortality in lethal murine models of infection.
International journal of molecular medicine 2005;16(1):165-71.
2005: Sonia Schoonbroodt; Nicolas Frans; Mark DeSouza; Rachel Eren; Smadar Priel; Naama Brosh; Judith Ben-Porath; Arie Zauberman; Ehud Ilan; Shlomo Dagan; Edward H Cohen; Hennie Hoogenboom; Robert C Ladner; René M Hoet
Oligonucleotide-assisted cleavage and ligation: a novel directional DNA cloning technology to capture cDNAs. Application in the construction of a human immune antibody phage-display library.
Nucleic acids research 2005;33(9):e81.
2004: Negba Hanuka; Emanuel Sikuler; David Tovbin; Lewis F Neville; Ofer Nussbaum; Marcus Mostoslavsky; Mordechai Orgel; Arieh Yaari; Sigal Manor; Shlomo Dagan; Nir Hilzenrat; Yonat Shemer-Avni
Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
Journal of medical virology 2004;73(4):529-35.
2003: Shlomo Dagan; Rachel Eren
Therapeutic antibodies against viral hepatitis.
Current opinion in molecular therapeutics 2003;5(2):148-55.
2002: Ehud Ilan; Rachel Eren; Ido Lubin; Ofer Nussbaum; Arie Zauberman; Shlomo Dagan
The Trimera mouse: a system for generating human monoclonal antibodies and modeling human diseases.
Current opinion in molecular therapeutics 2002;4(2):102-9.
2002: Eithan Galun; Rachel Eren; Rifaat Safadi; Yaffa Ashour; Norah A Terrault; Emmet B Keeffe; Edith Matot; Sara Mizrachi; Dov Terkieltaub; Merav Zohar; Ido Lubin; Judith Gopher; Daniel Shouval; Shlomo Dagan
Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties.
Hepatology (Baltimore, Md.) 2002;35(3):673-9.
2002: Ehud Ilan; Eden Arazi; Ofer Nussbaum; Arie Zauberman; Rachel Eren; Ido Lubin; Lewis F Neville; Ofer Ben-Moshe; Alberto Kischitzky; Amir Litchi; Ido Margalit; Judith Gopher; Samir Mounir; Weizhong Cai; Nili Daudi; Ahmed Eid; Oded Jurim; Abraham Czerniak; Eithan Galun; Shlomo Dagan
The hepatitis C virus (HCV)-Trimera mouse: a model for evaluation of agents against HCV.
The Journal of infectious diseases 2002;185(2):153-61.
2000: Rachel Eren; Ehud Ilan; Ofer Nussbaum; Ido Lubin; Dov Terkieltaub; Eden Arazi; Ofer Ben-Moshe; A Kitchinzky; S Berr; Judith Gopher; Arie Zauberman; Eithan Galun; Daniel Shouval; Nili Daudi; Ahmed Eid; Oded Jurim; L O Magnius; B Hammas; Yair Reisner; Shlomo Dagan
Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees.
Hepatology (Baltimore, Md.) 2000;32(3):588-96.
2000: Eithan Galun; O Nahor; Ahmed Eid; Oded Jurim; S Rose-John; H E Blum; Ofer Nussbaum; Ehud Ilan; Nili Daudi; Daniel Shouval; Yair Reisner; Shlomo Dagan
Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo.
Virology 2000;270(2):299-309.
1999: Ray F Schinazi; Ehud Ilan; P L Black; X Yao; Shlomo Dagan
Cell-based and animal models for hepatitis B and C viruses.
Antiviral chemistry & chemotherapy 1999;10(3):99-114.
1999: Ehud Ilan; Tatyana Burakova; Shlomo Dagan; Ofer Nussbaum; Ido Lubin; Rachel Eren; Ofer Ben-Moshe; Eden Arazi; S Berr; Lewis F Neville; L Yuen; TS Mansour; J Gillard; Ahmed Eid; Oded Jurim; Daniel Shouval; Yair Reisner; Eithan Galun
The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents.
Hepatology (Baltimore, Md.) 1999;29(2):553-62.
1998: Yair Reisner; Shlomo Dagan
The Trimera mouse: generating human monoclonal antibodies and an animal model for human diseases.
Trends in biotechnology 1998;16(6):242-6.
1998: Rachel Eren; Ido Lubin; Dov Terkieltaub; Ofer Ben-Moshe; Arie Zauberman; R Uhlmann; T Tzahor; S Moss; Ehud Ilan; Daniel Shouval; Eithan Galun; Nili Daudi; Hadar Marcus; Yair Reisner; Shlomo Dagan
Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system.
Immunology 1998;93(2):154-61.
1997: A Klein; R Barsuk; Shlomo Dagan; O Nusbaum; Daniel Shouval; Eithan Galun
Comparison of methods for extraction of nucleic acid from hemolytic serum for PCR amplification of hepatitis B virus DNA sequences.
Journal of clinical microbiology 1997;35(7):1897-9.
1994: Zvi Spirer; RAVIT BOGER; V Zakuth; Esther Tzehoval; Shlomo Dagan; B Lev; A Golander; I Melamed
[Decreased interleukin-1 and interleukin-2 production after splenectomy].
Harefuah 1994;126(7):374-7, 426.
1991: Raniero Rocchi; Laura Biondi; Fernando Filira; Esther Tzehoval; Shlomo Dagan; Mati Fridkin
Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production.
International journal of peptide and protein research 1991;37(3):161-6.
1990: R Surkis; S Rubinraut; Shlomo Dagan; Esther Tzehoval; Mati Fridkin; R Ben Yoseph; R Catane
Polytuftsin: a potential precursor for slow release of the phagocytosis stimulating peptide tuftsin.
The International journal of biochemistry 1990;22(2):193-5.
1989: Zvi Spirer; V Zakuth; Esther Tzehoval; Shlomo Dagan; Mati Fridkin; A Golander; I Melamed
Tuftsin stimulates IL-1 production by human mononuclear cells, human spleen cells and mouse spleen cells in vitro.
Journal of clinical & laboratory immunology 1989;28(1):27-31.
1989: Esther Tzehoval; Shlomo Dagan; Lea Eisenbach; J Atsmon; M Feldman
Immunogenic capacity of macrophage hybridomas.
European journal of immunology 1989;19(1):89-96.
1988: Shlomo Dagan; Esther Tzehoval; B Tartakovsky; Mati Fridkin; M Feldman
Antigen-tuftsin conjugate signals interleukin-1 synthesis and secretion.
Journal of biological response modifiers 1988;7(6):546-58.
1987: Shlomo Dagan; Esther Tzehoval; Mati Fridkin; M Feldman
Tuftsin and tuftsin conjugates potentiate immunogenic processes: effects and possible mechanisms.
Journal of biological response modifiers 1987;6(6):625-36.
1987: Raniero Rocchi; Laura Biondi; F Cavaggion; Fernando Filira; Marina Gobbo; Shlomo Dagan; Mati Fridkin
Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.
International journal of peptide and protein research 1987;29(2):262-75.
1987: Raniero Rocchi; Laura Biondi; Fernando Filira; Marina Gobbo; Shlomo Dagan; Mati Fridkin
Synthesis of modified tuftsins containing monosaccharides or monosaccharide derivatives.
International journal of peptide and protein research 1987;29(2):250-61.
1986: J Atsmon; Shlomo Dagan; E Zehoval
[Tuftsin].
Harefuah 1986;111(11):384-7.
1986: Shlomo Dagan; P Gottlieb; Esther Tzehoval; M Feldman; Mati Fridkin; K Yasumura; K Okamoto; H Yajima
Tuftsin analogues: synthesis, structure-function relationships, and implications for specificity of tuftsin's bioactivity.
Journal of medicinal chemistry 1986;29(10):1961-8.